Economic analysis of a herpes zoster vaccination program in 19 affiliated supermarket pharmacies

Journal of the American Pharmacists Association

Volumn 54, Issue 4, 2014, Pages 390-396

  Hedden, Megan A ^a   Kuehl, Peggy G ^b,c   Liu, Yifei ^b  

^a AuBurn Pharmacy   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UMKC   (United States)

Author keywords

Community pharmacy; Economic analysis; Herpes zoster; Pharmacist; Vaccination

Indexed keywords

VARICELLA ZOSTER VACCINE;

ARTICLE; ECONOMIC EVALUATION; HERPES ZOSTER; HUMAN; IMMUNIZATION; PHARMACIST; PHARMACY; PHARMACY TECHNICIAN; PROFIT; VACCINATION; ECONOMICS; IMMUNOLOGY; UNITED STATES;

COMMUNITY PHARMACY SERVICES; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; KANSAS; PHARMACIES; VACCINATION;

EID: 84907330511     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2014.13140     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. Shingles (herpes zoster): clinical overview. www.cdc.gov/shingles/hcp/clinicaloverview.html. Accessed May 31, 2014.
2. Centers for Disease Control and Prevention. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2008;57(RR-5):1-30.
3. Centers for Disease Control and Prevention. Noninfluenza vaccination coverage among adults-United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63:95-102.
4. Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: pharmacists' participation and impact. J Am Pharm Assoc. 2003;43(4):470-482.
5. McDonough RP, Doucette WR. Using personal selling skills to promote pharmacy services. J Am Pharm Assoc. 2003;43:363-374.
6. Bryan AR, Liu Y, Kuehl PG. Advocating zoster vaccination in a community pharmacy through use of personal selling. J Am Pharm Assoc. 2013;53(1):70-77.
7. National Community Pharmacists Association. 2012 NCPA digest in-brief. www.ncpanet.org/pdf/digest/2012/2012-digest-inbrief.pdf. Accessed May 31, 2014.
8. Wood HM, McDonough RP, Doucette WR. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective. J Am Pharm Assoc. 2009;49(1):12-17.
9. Meltzer, MI. Introduction to health economics for physicians. Lancet. 2001;358(9286):993-998. (Pubitemid 32913530)
10. Zostavax [package insert]. Whitehouse Station, NJ: Merck & Co., Inc.;2007.
11. Rascati KL. Essentials of pharmacoeconomics. Philadelphia, PA: Lippincott Williams & Wilkins; 2009.
12. Anonymous. The shingles vaccine: why hasn't it caught on? The cost and other factors are to blame. Harv Health Lett. 2007;32(10):1-2.
13. Holdford DA. Marketing for pharmacists. 2nd ed. Washington, DC: American Pharmacists Association; 2007.